-- Robert Preidt
FRIDAY, July 26 (HealthDay News) -- Important differences
between Middle East respiratory syndrome (MERS) and severe acute
respiratory syndrome (SARS) suggest that MERS won't prove as
dangerous as SARS, researchers report.
MERS emerged last year in Saudi Arabia and nearly all cases of
infection have been reported there, or in people who were infected
with the virus there before traveling to other countries. Between
Sept. 1, 2012, and June 15, 2013, there were 47 confirmed cases (46
adults, one child) of MERS infections in Saudi Arabia, according to
the report published July 25 in
The Lancet Infectious Diseases.
As of July 24, the U.S. Centers for Disease Control and
Prevention said there had been 90 MERS cases worldwide.
An analysis of clinical records, laboratory results and other
data revealed that older people, men and patients with chronic
health problems are more likely to succumb to the disease, the
Like those infected with SARS, people with MERS have a wide
range of symptoms. Most patients admitted to the hospital had fever
(98 percent), chills (87 percent), cough (83 percent), shortness of
breath (72 percent) and muscle pain (32 percent). One-fourth of
patients also had gastrointestinal symptoms, such as vomiting and
Unlike SARS, however, nearly all of the cases of MERS occurred
in people with chronic health conditions, such as diabetes (68
percent), high blood pressure (34 percent), chronic heart disease
(28 percent) and chronic kidney disease (49 percent).
"Despite sharing some clinical similarities with SARS (e.g., fever, cough and incubation period), there are also some important differences, such as the rapid progression to respiratory failure, up to five days earlier than SARS," study leader Ziad Memish, the deputy minister for public health from the Kingdom of Saudi Arabia, said in a journal news release.
"In contrast to SARS -- which was much more infectious, especially in health-care settings, and affected the healthier and the younger age group -- MERS appears to be more deadly, with 60 percent of patients with co-existing chronic illnesses dying, compared with the 1 percent to 2 percent toll of SARS," Memish said.
"Although this high mortality rate with MERS is probably spurious due to the fact that we are only picking up severe cases and missing a significant number of milder or asymptomatic cases, so far there is little to indicate that MERS will follow a similar path to SARS," Memish added.
Study co-author Ali Zumla, from University College London in the
United Kingdom, said that "the recent identification of milder or
asymptomatic cases of MERS in health-care workers, children and
family members of contacts of MERS cases indicates that we are only
reporting the tip of the iceberg of severe cases and there is a
spectrum of milder clinical disease which requires urgent
"Ultimately, the key will be to identify the source of MERS infection, predisposing factors for susceptibility to infection and the predictive factors for poor outcome," Zumla said in the news release. "Meanwhile, infection control measures within hospitals seem to work."
In an editorial accompanying the report, Christian Drosten, of
the University of Bonn Medical Center in Germany, said there is an
urgent need to develop accurate diagnostic tests to help focus
efforts to control MERS and to minimize the risk of it spreading
from infected patients to other people.
The U.S. Centers for Disease Control and Prevention has more
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.